Prior authorization for orthopedic and spine procedures.
Orthopedics now carries two separate prior-authorization layers that don't move at the same speed or by the same rules: CMS's new WISeR model gating certain fee-for-service Medicare claims in a handful of states, and commercial payers' long-standing, and often stricter, conservative-treatment-failure requirements for joint replacement and spinal fusion. Confusing the two — or treating either as a coverage decision rather than a process gate — is how a covered, medically necessary procedure ends up denied anyway.
Key takeaways
- WISeR is a process gate, not a coverage change. It adds algorithm-screened prior authorization to traditional Medicare for 17 spine and orthopedic procedures in a limited set of states starting January 1, 2026 — a covered procedure is still covered, it just may need sign-off first.
- Joint replacement and spinal fusion carry the industry's highest first-submission denial rate of any orthopedic category, and almost always for the same root cause: incomplete conservative-treatment documentation, not a genuine coverage dispute.
- Commercial conservative-care thresholds are payer-specific and frequently stricter than any Medicare LCD. A visit count, a duration, or an injection requirement that satisfies one payer's policy won't automatically satisfy another's.
- An ABN only protects you if it's specific and signed before the service. GA (ABN on file) and GZ (no ABN, expected denial) tell the payer two very different things about who's financially exposed if the claim denies.
CMS's WISeR model: what it actually changes
The Wasteful and Inappropriate Service Reduction (WISeR) model brought prior authorization to traditional fee-for-service Medicare for the first time, effective January 1, 2026. It covers 17 procedures spanning spine and orthopedic care, including spinal fusion and epidural steroid injections, and it's currently live in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. A third-party review entity screens requests using an algorithm, but CMS requires a licensed clinician to personally review and sign off on every denial — the algorithm can't be the final word on a rejected request. CMS has also said it plans to pilot a "gold carding" exemption by mid-2026 that would spare high-volume surgeons with strong approval-rate histories from repeated authorization requirements, though the mechanics of who qualifies haven't been finalized.
The distinction that matters operationally: WISeR changes the process in front of a claim, not the underlying coverage or payment rule behind it. A spinal fusion that was medically necessary and covered under traditional Medicare on December 31, 2025 is still covered on January 1, 2026 in a WISeR state — it just needs authorization secured first, the same way a commercial payer's prior-auth requirement doesn't change what that payer covers. Practices in a live WISeR state that treat a denial from the model as a medical-necessity fight, rather than an authorization-process problem, waste the appeal on the wrong argument.
⚠️ The 17-procedure category list, the specific six-state footprint, and the gold-carding pilot timeline above reflect this build's sourcing of current healthcare-industry and CMS-adjacent reporting on the WISeR model, consistent with this site's orthopedics pillar guide; no dedicated CMS payment-model connector was available to re-verify the current state list directly against CMS's own WISeR page during this build (CMS.gov returned an access error to automated retrieval), and WISeR's state and procedure footprint is the kind of detail CMS can expand. Confirm the current participating states and the full procedure list on CMS's WISeR model page before relying on it for a specific claim.
Commercial prior authorization: conservative-treatment documentation
Independent of WISeR, commercial payers run their own prior-authorization programs for the two orthopedic procedure categories that generate the most volume and the most cost: total joint arthroplasty and spinal fusion. These are widely reported by industry claims-denial benchmarking to carry the highest first-submission denial rate of any orthopedic procedure category, and the recurring root cause across payers isn't a genuine coverage dispute — it's incomplete documentation of the conservative-treatment trial the payer's policy requires before it will authorize surgery.
| Element | What payers look for |
|---|---|
| Physical therapy | A documented course over a specific duration or visit count, with notes reflecting response (or lack of response) to treatment — a referral alone, without evidence the patient attended and how they responded, rarely satisfies this |
| Pharmacologic trial | NSAIDs or other analgesics tried and documented as inadequate, including any contraindication if they weren't used |
| Injection history | For joint replacement specifically, a corticosteroid or viscosupplementation injection is commonly required as evidence conservative options were exhausted, not skipped |
| Imaging correlation | Imaging findings that match the reported symptoms and the specific joint or spinal level — imaging showing pathology at a different level than the symptomatic one is a common source of a mismatch denial |
| Functional impact | Documentation of how the condition limits daily function, not just a pain rating in isolation |
The failure pattern we see most: the conservative treatment genuinely happened, but the chart doesn't reflect it in a form the payer's review can act on — a therapy referral was sent but the record never confirms the patient completed a course, or an injection was administered at another practice and the records were never obtained and attached to the authorization request. The surgery may be entirely appropriate; the request still gets denied, or the claim denies after the fact, because the documentation submitted doesn't prove it.
- Pull the specific payer's conservative-care policy before scheduling, not after the authorization request is denied.
- Request and attach outside records (PT notes, injection records from another practice) rather than assuming the payer will find them.
- Verify WISeR authorization status against the exact procedure code and date of service in a live state, every time.
- Don't assume a Medicare LCD's conservative-care threshold satisfies a commercial payer's stricter policy.
- Don't treat a WISeR or commercial prior-auth denial as a medical-necessity appeal when it's actually an authorization-process gap.
- Don't schedule surgery on the assumption that authorization will follow — confirm it's secured first.
ABNs when medical necessity is doubtful
An Advance Beneficiary Notice matters specifically when you have a genuine, documented reason to expect Medicare might deny a service as not medically necessary — most often because the conservative-treatment documentation is thinner than the governing LCD's threshold, or the procedure sits at the edge of a covered indication rather than squarely inside it. The notice has to be specific to the service, given and signed before the procedure, and written in terms the patient can actually understand; a blanket ABN signed at intake for "any service that might not be covered" doesn't hold up if it's challenged.
- GAABN on file. A valid, signed ABN exists for this specific service. If Medicare denies, financial liability shifts to the patient, and the practice can bill them for the service.
- GZNo ABN obtained, denial expected. The practice believes the service will be denied as not medically necessary but didn't secure a signed ABN beforehand. This generally means the practice cannot bill the patient if the claim denies — the financial exposure stays with the practice, not the patient.
The practical discipline this requires: flag a case as borderline before the day of surgery, not the morning of, so there's time to review the specific LCD threshold against what's actually documented and get a properly specific ABN signed if the gap is real. A GZ claim submitted because nobody caught the documentation gap until the day of the procedure is an entirely avoidable loss.
Build a single pre-surgical checklist that runs both authorization tracks at once: confirm WISeR status by exact CPT code and date of service if you operate in a live state, and separately confirm the specific payer's conservative-care documentation against what's actually in the chart. Treating these as one combined "prior auth" task instead of two separate checks is exactly where a practice misses the commercial documentation gap while focused on the Medicare authorization number, or vice versa.
Losing joint replacement or fusion cases to authorization denials?
We'll review your pre-surgical documentation workflow against your top payers' actual conservative-care policies and flag the gaps before they cost you a case.
Frequently asked questions
How is CMS's WISeR model different from a change in Medicare coverage?
WISeR adds a prior-authorization checkpoint in front of certain traditional fee-for-service Medicare claims in its live states — it does not change what Medicare covers or how a covered procedure is paid. A procedure that was medically necessary and covered before WISeR is still covered; it just may need sign-off, screened by an algorithm with a licensed clinician required to approve every denial, before the claim is submitted. Treat it as a new gate in the process, not a new coverage policy, and don't let a WISeR denial get filed as a medical-necessity appeal when it's actually an authorization-process issue.
What conservative-treatment documentation do commercial payers require before approving a total joint replacement or spinal fusion?
Most commercial payers require a documented trial of conservative care that failed to resolve the condition before they'll authorize the surgery — typically a specific duration or visit count of physical therapy, a trial of NSAIDs or other analgesics, and for joint replacement often a corticosteroid or viscosupplementation injection, plus imaging that correlates with the reported symptoms. The specific thresholds — how many PT visits, how many weeks, which injection — vary by payer and plan, so the exact requirement has to be pulled from that payer's own policy rather than assumed from what Medicare's LCDs require, because commercial thresholds are frequently stricter.
When should we get an ABN signed before an orthopedic or spine procedure?
Get one signed whenever you have genuine reason to believe Medicare is likely to deny the service as not medically necessary — most often when the conservative-treatment documentation is thin relative to the LCD's threshold, or the procedure sits at the edge of a covered indication. The ABN has to be specific, given before the service, and signed before it's performed; a blanket ABN signed for every visit doesn't hold up. Bill with modifier GA when a valid ABN is on file, which allows the patient to be billed if Medicare denies; GZ signals no ABN was obtained and the service is still expected to deny, which generally means the practice can't bill the patient for it.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.